From R&D to clinical testing, successfully launching a new drug requires many signatures and approvals from stakeholders around the world. In order to make product development lifecycle efficient, a pharmaceutical organization can no longer afford to deal with paper and manual signature processes. So, MSB Docs is helping GSK eliminate such cumbersome paperwork.